Cancer-associated fibroblast activation predicts progression, metastasis, and prognosis of cutaneous squamous cell carcinoma

被引：0
|
作者：
Knuutila, J. [1 ]
Riihila, P. [1 ]
Nissinen, L. [1 ]
Kallionpaa, R. [3 ]
Pellinen, T. [2 ]
Kahari, V. [1 ]
机构：
[1] Turun Yliopisto, Laaketieteellinen Tiedekunta, Turku, Finland
[2] Helsingin Yliopisto, Helsinki, Uusimaa, Finland
[3] TYKS Turu Yliopistollinen Keskussairaala, Turku, Varsinais Suomi, Finland
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2023年 / 143卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
306
引用
收藏
页码：S52 / S52
页数：1
相关论文
共 50 条
  • [1] Cancer-associated fibroblast activation predicts progression, metastasis, and prognosis of cutaneous squamous cell carcinoma
    Knuutila, Jaakko S.
    Riihila, Pilvi
    Nissinen, Liisa
    Kallionpaa, Roosa
    Pellinen, Teijo
    Kahari, Veli-Matti
    CANCER RESEARCH, 2023, 83 (07)
  • [2] Cancer-associated fibroblast activation predicts progression, metastasis and prognosis of cutaneous squamous cell carcinoma
    Knuutila, J. S.
    Riihila, P.
    Nissinen, L.
    Kallionpaa, R.
    Pellinen, T.
    Kahari, V.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (12) : S261 - S261
  • [3] Cancer-associated fibroblast activation predicts progression, metastasis and prognosis of cutaneous squamous cell carcinoma
    Knuutila, J.
    Riihila, P.
    Nissinen, L.
    Kallionpaa, R.
    Pellinen, T.
    Kahari, V.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : B5 - B5
  • [4] Cancer-associated fibroblast activation predicts progression, metastasis, and prognosis of cutaneous squamous cell carcinoma
    Knuutila, Jaakko S.
    Riihila, Pilvi
    Nissinen, Liisa
    Heiskanen, Lauri
    Kallionpaa, Roosa E.
    Pellinen, Teijo
    Kahari, Veli-Matti
    INTERNATIONAL JOURNAL OF CANCER, 2024, 155 (06) : 1112 - 1127
  • [5] Identification of a cancer-associated fibroblast classifier for predicting prognosis and therapeutic response in lung squamous cell carcinoma
    Lai, Xixi
    Fu, Gangze
    Du, Haiyan
    Xie, Zuoliu
    Lin, Saifeng
    Li, Qiao
    Lin, Kuailu
    MEDICINE, 2023, 102 (38) : E35005
  • [6] Fibroblast Activation Protein (FAP) Expression of Cancer-Associated Fibroblast Predicts Poor Prognosis in Patients With Pancreatic
    Kawase, Tomoya
    Yoshida, Koji
    Hino, Keisuke
    GASTROENTEROLOGY, 2013, 144 (05) : S869 - S869
  • [7] Podoplanin Expression in Cancer-associated Fibroblasts Predicts Poor Prognosis in Patients with Squamous Cell Carcinoma of the Lung
    Yurugi, Yohei
    Wakahara, Makoto
    Matsuoka, Yuki
    Sakabe, Tomohiko
    Kubouchi, Yasuaki
    Haruki, Tomohiro
    Nosaka, Kanae
    Miwa, Ken
    Araki, Kunio
    Taniguchi, Yuji
    Shiomi, Tatsushi
    Nakamura, Hiroshige
    Umekita, Yoshihisa
    ANTICANCER RESEARCH, 2017, 37 (01) : 207 - 213
  • [8] Podoplanin Expression in Cancer-Associated Fibroblasts Predicts Poor Prognosis in Patients with Squamous Cell Carcinoma of the Lung
    Yurugi, Y.
    Fujiwara, W.
    Kidokoro, Y.
    Hosoya, K.
    Ohno, T.
    Sakabe, T.
    Kubouchi, Y.
    Wakahara, M.
    Takagi, Y.
    Haruki, T.
    Nosaka, K.
    Miwa, K.
    Araki, K.
    Taniguchi, Y.
    Shiomi, T.
    Nakamura, H.
    Umekita, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1945 - S1946
  • [9] Photoimmunotherapy for cancer-associated fibroblasts targeting fibroblast activation protein in human esophageal squamous cell carcinoma
    Watanabe, Shinichiro
    Noma, Kazuhiro
    Ohara, Toshiaki
    Kashima, Hajime
    Sato, Hiroaki
    Kato, Takuya
    Urano, Shinichi
    Katsube, Ryoichi
    Hashimoto, Yuuri
    Tazawa, Hiroshi
    Kagawa, Shunsuke
    Shirakawa, Yasuhiro
    Kobayashi, Hisataka
    Fujiwara, Toshiyoshi
    CANCER BIOLOGY & THERAPY, 2019, 20 (09) : 1234 - 1248
  • [10] Identifying the cancer-associated fibroblast signature to predict the prognosis and immunotherapy response in patients with lung squamous cell carcinoma
    Zhu, Yinhui
    Zhu, Yingqun
    Chen, Sirui
    Cai, Qian
    COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING, 2025, 28 (03) : 326 - 336
12345